Dld Asset Management, LP Vascular Biogenics Ltd. Transaction History

Dld Asset Management, LP

  • $204 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
BUY
$1.15 - $1.97 $143,750 - $246,250
125,000 Added 29.41%
550,000 $930,000
Q4 2021

Feb 14, 2022
BUY
$1.92 - $2.53 $816,000 - $1.08 Million
425,000 New
425,000 $837,000

Others Institutions Holding VBLT

# of Institutions
2
Shares Held
416K
Call Options Held
0
Put Options Held
0
View Full List

About Vascular Biogenics Ltd.

VBLT Quotes by TradingView
  • Ticker VBLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,348,896
  • Description
  • Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...
More about VBLT
Track This Portfolio

Track Dld Asset Management, LP Portfolio

Follow Dld Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Dld Asset Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email